About the Authors
- Ichiro Maruko
-
Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida
Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing
* E-mail: imaruko@twmu.ac.jp
Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan
- Hideki Koizumi
-
Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida
Roles Data curation, Writing – review & editing
Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan
- Taiji Hasegawa
-
Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida
Roles Data curation, Writing – review & editing
Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan
- Hisaya Arakawa
-
Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida
Roles Data curation, Writing – review & editing
Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan
- Tomohiro Iida
-
Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida
Roles Supervision, Writing – review & editing
Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan
Competing Interests
Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Cover Letter Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Koizumi reports grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from HOYA Corp., personal fees from Canon Inc., personal fees from Wakamoto Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work;. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. Iida reports grants and personal fees from Novartis Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work;. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.